Location: Guiyang
Synced from ClinicalTrials.gov · August 07, 2026
Clinical studies recruiting near Guiyang
Studies with at least one listed site matching this
location on the public registry. Each page explains the study in plain
language, with locations and study-team contacts.
Clinicians: generate a
printable list for your patient →
🔍 Search another city or condition
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line Phase 3 · The Affiliated Hospital of Guizhou Medical University ( Site · Merck Sharp & Dohme LLC · NCT06136559 Evaluation of Rovadicitinib Compared to the Protocol Selected by Researchers in Third Line and Subsequent Studies of Mod Phase 3 · The Affiliated Hospital of Guizhou Medical University · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · NCT06682169 IDEAL Study: Blinded RCT for the Impact of AI Model for Cerebral Aneurysms Detection on Patients' Diagnosis and Outcomes NA · Guizhou Provincial People's Hospital · Jinling Hospital, China · NCT06118840 A Study of TQB2102 for Injection in the Treatment of HER2-positive Biliary Tract Cancer Phase 1/Phase 2 · The Affiliated Hospital of Guizhou Medical University · Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharm · NCT06431490 Artificial Intelligence-driven Virtual Standardized Pediatric Patients Trial NA · Yuntan Street Community Health Center · Southern Medical University, China · NCT06699433 The Chinese Familial Alzheimer's Network Phase N/A · The Affiliated Hospital Of Guizhou Medical University · Capital Medical University · NCT03657732 Phase II/III Study of SPH4336 Combined With Letrozole vs Placebo Combined With Letrozole in First-line Treatment of Brea Phase 2/Phase 3 · The Affiliated Cancer Hospital of Guizhou Medical University · Shanghai Pharmaceuticals Holding Co., Ltd · NCT05744687 Chinese Adults With Kidney Disease Phase 2 · ADARx Clinical Site · ADARx Pharmaceuticals, Inc. · NCT07522099 Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis Phase 3 · Guizhou Provincial People's Hospital · Gilead Sciences · NCT06051617 Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis Phase N/A · Research Site · AstraZeneca · NCT06465810 China HeadAche DIsorders RegiStry Phase N/A · The Second People's Hospital of Guiyang · Beijing Tiantan Hospital · NCT05334927 A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Primary Membranous Nephropath Phase 3 · The Affiliated Hospital of Guizhou Medical University · Biogen · NCT06962800 Clinical Study on the Efficacy and Safety of TNTL in the Treatment of Non-proliferative Diabetic Retinopathy Phase 3 · The First Affiliated Hospital of Guizhou University of Tradi · Beletalent (Zhuhai) Pharmaceutical Co., Ltd · NCT06817265 Reduced-dose Radiotherapy for Stage III Nasopharyngeal Carcinoma Based on the Treatment Response Phase 3 · Cancer Hospital of Guizhou Medical University · Sun Yat-sen University · NCT06239727 Study of the Key Techniques of Prevention and Treatment of Osteoporotic Refracture NA · Affiliated Hospital of Guizhou Medical University · Peking Union Medical College Hospital · NCT05866029 A Study of Lianxiaxiaopi Granules in the Treatment of Postprandial Distress Syndrome Phase 3 · The First Affiliated Hospital of Guizhou University of Tradi · Tasly Pharmaceutical Group Co., Ltd · NCT06696261 REmimazolam vs Propofol Total Intravenous Anesthesia on Outcomes After Major Noncardiac SurgEry Phase 4 · The Affiliated Hospital of Guizhou Medical University · Nanfang Hospital, Southern Medical University · NCT05728775 Prediction of Peritoneal Metastasis for Gastric Cancer Based on Radiomics Phase N/A · Guizhou Provincial People's Hospital · Chinese Academy of Sciences · NCT05722275 A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel Phase 3 · People's Hospital of Guizhou Province /ID# 243614 · AbbVie · NCT04928846 A Study of MI078 for Postpartum Depression Phase 3 · Guizhou Provincial People's Hospital · Nanjing Minova Pharmaceutical Co., Ltd. · NCT07721961 Clinical Trial Comparing TQB2868 Injection Combined With Anlotinib Hydrochloride Capsules With Placebo Combined With Che Phase 3 · Guizhou Medical University Affiliated Cancer Hospital Co., L · Shanghai Chia Tai Tianqing Pharmaceutical Technology Develop · NCT07165951 Clinical Study on the Efficacy and Safety of LM-302 Injection Combined With Tislelizumab and Tislelizumab Combined Chemo Phase 3 · The People's Hospital of Guizhou Province · Shanghai Chia Tai Tianqing Pharmaceutical Technology Develop · NCT07385703 Treatment of Vasospasm of Aneurysmal Subarachnoid Hemorrhage With Intrathecal Nicardipine - FAST-IT Trial NA · Jinyang Hospital Affiliated to Guizhou Medical University · The Affiliated Hospital Of Guizhou Medical University · NCT06329635 Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Phase 3 · Research Site · AstraZeneca · NCT06921785 Newly-diagnosed Pediatric Ph-positive B-ALL Protocol Phase 3 · The Affiliated Hospital of Guizhou Medical University · Institute of Hematology & Blood Diseases Hospital, China · NCT07152041 A Phase Ⅰb/Ⅱa Clinical Study of IMC-003 Injection for the Treatment of Pulmonary Arterial Hypertension Receiving Backgro Phase 1/Phase 2 · The Affiliated Hospital of Guizhou Medical University · ImmuneCare Biopharmaceuticals (Shanghai) Co., Ltd. · NCT07593027 ctDNA-MRD Guided Escalation of Ivonescimab and Docetaxel in Advanced NSCLC With Long-Term Responses to First-line Immuno Phase 2 · Guiyang Public Health Clinical Center · Second Xiangya Hospital of Central South University · NCT06951646 An Exploratory Study of Individualized Neo-antigen mRNA Cancer Vaccine InnoPCV in Advanced Solid Tumor Treatment EARLY_Phase 1 · The Affiliated Hospital of Guizhou Medical University · The Affiliated Hospital Of Guizhou Medical University · NCT06497010 Comparing Modified XELOX Plus Sintilimab With Standard XELOX Plus Sintilimab in First-line Treatment for HER2-negative G Phase 3 · The Affliated Cancer Hospital of Guizhou Medical University · Sun Yat-sen University · NCT05918094 Research on the Mechanism Affecting Progression of Bronchiectasis Phase N/A · Guizhou Provincial people's Hospital · Union Hospital, Tongji Medical College, Huazhong University · NCT05731427
Look up another city
Look up another condition